← Leaderboards
Rosandra Kaplan
Division Of Basic Sciences - Nci
$454,987
Attributed
$1,364,962
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $448.2K · FY2018–21$500K$375K$250K$125K$0
'18
'19
'20
'21
Funding mix
By agency
NIH$1,364,962 · 1
By mechanism
U01$1,364,962 · 1
Top collaborators
- Catherine C Hedrick4 shared
- David Fran Stroncek4 shared
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Other Emerging Leaders on “Tumor”
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Lynn Briscoe · Leidos Biomedical Research, Inc.$120,794,323
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$105,180,681
- Leonard Freedmand · Leidos Biomedical Research, Inc.$78,762,245
- Connie Suders · Leidos Biomedical Research, Inc.$67,882,919
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
Research focus
TumorTumor ProgressionCellsResponseMalignant NeoplasmsSiteNeoplasm MetastasisPrimary NeoplasmNeoplastic CellBone MarrowAreaInvestigationHematopoieticTherapy DesignBlood VesselsAdultHematopoietic Stem CellsDistantImmuneMyeloid CellsTissuesStem CellsSamplingStromal Cells
Grant awards (36)
Biomarkers and Therapeutic Targets in Tumor Microenvironment and Metastasis$1,030,688
ZIA · FY2025 · CA · contact PI
Tumor Microenvironment in Cancer Progression$1,030,688
ZIA · FY2025 · CA · contact PI
Biomarkers and Therapeutic Targets in Tumor Microenvironment and Metastasis$1,339,057
ZIA · FY2024 · CA · contact PI
Tumor Microenvironment in Cancer Progression$1,339,057
ZIA · FY2024 · CA · contact PI
Tumor Microenvironment in Cancer Progression$1,190,749
ZIA · FY2023 · CA · contact PI
Biomarkers and Therapeutic Targets in Tumor Microenvironment and Metastasis$1,190,749
ZIA · FY2023 · CA · contact PI
Tumor Microenvironment in Cancer Progression$1,116,420
ZIA · FY2022 · CA · contact PI
Biomarkers and Therapeutic Targets in Tumor Microenvironment and Metastasis$1,116,420
ZIA · FY2022 · CA · contact PI
Biomarkers and Therapeutic Targets in Tumor Microenvironment and Metastasis$954,297
ZIA · FY2021 · CA · contact PI
Tumor Microenvironment in Cancer Progression$954,297
ZIA · FY2021 · CA · contact PI
Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers$136,148
U01 · FY2021 · CA
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis$676,757
ZIA · FY2020 · CA · contact PI
Tumor Microenvironment in Cancer Progression$676,757
ZIA · FY2020 · CA · contact PI
Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers$448,200
U01 · FY2020 · CA
Tumor Microenvironment in Cancer Progression$536,966
ZIA · FY2019 · CA · contact PI
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis$536,966
ZIA · FY2019 · CA · contact PI
Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers$362,294
U01 · FY2019 · CA
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis$534,706
ZIA · FY2018 · CA · contact PI
Tumor Microenvironment in Cancer Progression$534,706
ZIA · FY2018 · CA · contact PI
Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers$418,320
U01 · FY2018 · CA
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis$661,011
ZIA · FY2017 · CA · contact PI
Tumor Microenvironment in Cancer Progression$661,011
ZIA · FY2017 · CA · contact PI
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis$515,673
ZIA · FY2016 · CA · contact PI
Tumor Microenvironment in Cancer Progression$515,673
ZIA · FY2016 · CA · contact PI
Tumor Microenvironment in Cancer Progression$525,122
ZIA · FY2015 · CA · contact PI
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis$525,122
ZIA · FY2015 · CA · contact PI
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis$513,579
ZIA · FY2014 · CA · contact PI
Tumor Microenvironment in Cancer Progression$513,579
ZIA · FY2014 · CA · contact PI
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis$469,570
ZIA · FY2013 · CA · contact PI
Tumor Microenvironment in Cancer Progression$469,570
ZIA · FY2013 · CA · contact PI
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis$488,066
ZIA · FY2012 · CA · contact PI
Tumor Microenvironment in Cancer Progression$488,066
ZIA · FY2012 · CA · contact PI
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis$264,560
ZIA · FY2011 · CA · contact PI
Tumor Microenvironment in Cancer Progression$264,560
ZIA · FY2011 · CA · contact PI
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis$13,124
ZIA · FY2010 · CA · contact PI
Tumor Microenvironment in Cancer Progression$13,124
ZIA · FY2010 · CA · contact PI